Skip to content

Causal Variant Discovery

Introduction to Causal Variant Discovery

High-throughput genomic technologies enable researchers to screen large sample numbers quickly to find disease-related causal variants. Many single nucleotide polymorphisms (SNPs) and copy number variations (CNVs) are associated with disease.

Causal variant identification can lead to further studies of gene targets to characterize disease mechanisms.

Understanding Variation Through eQTL Webinar
Understanding Function Through Genetic Data

Dr. Tuuli Lappalainen discusses integrating genome and transcriptome sequencing data to understand functional variation in human genomes.

SNP Genotyping to Identify Causal Variants

SNP Genotyping to Identify Causal Variants

Large-scale investigations of the genome can be performed using arrays or next-generation sequencing (NGS). These surveys can generate statistically significant disease associations and identify potential causal variants of interest for future studies.

Identifying SNPs Using Arrays

Large-scale genome-wide association studies (GWAS) using arrays enable you to interrogate tens of thousands of samples at one time. GWAS are effective for identifying common variants associated with disease, uncovering multiple genes for further study.

Identifying SNPs Using NGS

While arrays are effective for finding common variants, they are limited in detecting rare variants. Whole-genome and whole-exome sequencing are common approaches for finding causal variants in rare or complex disease cases. Sequencing individuals or trios is a sensitive, unbiased approach to variant detection that can potentially reveal more variants than array-based approaches.


Complex Disease Research

Genomic technologies are introducing new avenues for understanding complex disease etiology on a molecular level.

Learn More
DNA helix
CNV Detection for Causal Variant Discovery

CNV Detection for Causal Variant Discovery

CNVs are genomic alterations that result in an abnormal number of copies of one or more genes. They are usually caused by structural rearrangements. Like SNPs, certain CNVs have been associated with disease susceptibility.

Detecting CNVs Using Arrays

Array-based approaches for detecting de novo CNVs (not present in or transmitted by either parent) offer efficient and reliable large-scale analysis. You can profile genomic variations such as amplifications, deletions, rearrangements, and copy-neutral loss of heterozygosity.

Illumina offers several types of array solutions for CNV detection, to facilitate causal variant discovery:

  • The CytoSNP-850K BeadChip provides comprehensive coverage of cytogenetically relevant genes correlated with high disease risk.
  • Human genotyping arrays make cost-effective, large-scale genome-wide and phenome-wide association studies possible.
Detecting CNVs Using NGS

While efficient for large CNV detection, genotyping arrays are less sensitive for small CNVs (< 50 kilobases). NGS offers base-pair resolution that can detect the small CNVs missed by arrays. This knowledge can be useful for studies of missing heritability in complex diseases. The high resolution of sequencing complements the high throughput of arrays, enabling a complete view of the genome.


Recent Developments in Disease Research

DRAGEN Shines at PrecisionFDA Truth Challenge
DRAGEN Shines at PrecisionFDA Truth Challenge

Illumina sequencing and software analysis are best in class for accuracy

Read Article
Single-Cell Analysis is Advancing Insights in Developmental Biology
Single-Cell Analysis is Advancing Insights in Developmental Biology

A computer scientist transforms the world of biology by making bioinformatics tools available to all.

Read Interview
DNA Tandem Repeats Implicated in ASD
DNA Tandem Repeats Implicated in ASD

Illumina technology plays role in unique population study

Read Article
Interested in receiving newsletters, case studies, and information from Illumina based on your area of interest? Sign up now.

Related Links

Target Enrichment

Reliably sequence exomes or large numbers of genes (e.g. > 50 genes) using robust hybridization-based enrichment workflows.

Pharmacogenomics and Cardiovascular Disease

See how researchers used an Illumina microarray to identify responder genotypes in a failed cholesterol drug trial.

Genome-Wide Association Studies

Genome-wide association studies (GWAS) enable researchers to scan entire genomes of large numbers of subjects quickly in order to find disease-associated variants.